Status:

COMPLETED

Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State

Lead Sponsor:

Methodist Rehabilitation Center

Collaborating Sponsors:

U.S. Department of Education

Conditions:

Traumatic Brain Injury

Posttraumatic Confusional State

Eligibility:

All Genders

16-65 years

Phase:

PHASE4

Brief Summary

Patients with traumatic brain injury often experience a period of acute confusion that may include agitation as they recover from their injuries. While this confusion generally resolves with time, pat...

Detailed Description

Patients with TBI who require inpatient rehabilitation are frequently confused at the time of admission for rehabilitation. Our investigations of confusion conducted as part of the TBIMSM have clarifi...

Eligibility Criteria

Inclusion

  • Acute Traumatic Brain Injury (≤90 days postinjury)
  • Responsive (not fulfilling criteria for Minimally Conscious State)
  • Meet PTCS criteria on 2 consecutive examinations (as determined by the Confusion Assessment Protocol)
  • Initial neurorehabilitation hospital admission
  • Anticipated ≥2 week length-of-stay after meeting PTCS criteria

Exclusion

  • Preexisting seizure disorder
  • Prior history of hospitalization for psychiatric condition

Key Trial Info

Start Date :

April 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2019

Estimated Enrollment :

79 Patients enrolled

Trial Details

Trial ID

NCT00693121

Start Date

April 1 2003

End Date

March 1 2019

Last Update

October 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Methodist Rehabilitation Center

Jackson, Mississippi, United States, 39216

Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State | DecenTrialz